Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?"

Clicks: 253
ID: 106942
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
ceccarelli2020letterpharmacological Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ceccarelli, Gabriele;Nardi, Katiuscia;Marchesani, Francesca;
Journal pharmacological research
Year 2020
DOI
S1043-6618(20)31241-X
URL
Keywords
traditional chinese medicine rutin (pubchem cid: 5280805) network pharmacology action mechanism quercetin (pubchem cid: 5280343) kaempferol (pubchem cid: 5280863) covid-19 sars-cov-2 ace2 3cl pro baicalein (pubchem cid: 5281605) isorhamnetin (pubchem cid: 5281654) luteolin (pubchem cid: 5280445) naringenin (pubchem cid: 932) ursolic acid (pubchem cid: 64945) wogonin (pubchem cid: 5281703) β-sitosterol (pubchem cid: 222284)

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.